These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 7610936

  • 1. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion.
    Garnero P, Gineyts E, Arbault P, Christiansen C, Delmas PD.
    J Bone Miner Res; 1995 Apr; 10(4):641-9. PubMed ID: 7610936
    [Abstract] [Full Text] [Related]

  • 2. Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease.
    Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F.
    J Bone Miner Res; 1993 May; 8(5):643-8. PubMed ID: 8511992
    [Abstract] [Full Text] [Related]

  • 3. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P, Gineyts E, Schaffer AV, Seaman J, Delmas PD.
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [Abstract] [Full Text] [Related]

  • 4. The renal clearance of free and peptide-bound deoxypyridinoline: response to pamidronate treatment of Paget's disease.
    Naylor KE, Jackson B, Eastell R.
    J Bone Miner Res; 2003 Apr; 18(4):658-61. PubMed ID: 12674326
    [Abstract] [Full Text] [Related]

  • 5. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P, Gineyts E, Riou JP, Delmas PD.
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [Abstract] [Full Text] [Related]

  • 6. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Randall AG, Kent GN, Garcia-Webb P, Bhagat CI, Pearce DJ, Gutteridge DH, Prince RL, Stewart G, Stuckey B, Will RK, Retallack RW, Price RI, Ward L.
    J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
    [Abstract] [Full Text] [Related]

  • 7. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 8. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

  • 9. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD.
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [Abstract] [Full Text] [Related]

  • 10. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
    Cloos PA, Fledelius C, Christgau S, Christiansen C, Engsig M, Delmas P, Body JJ, Garnero P.
    Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
    [Abstract] [Full Text] [Related]

  • 11. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study.
    Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD.
    J Bone Miner Res; 1996 Oct; 11(10):1531-8. PubMed ID: 8889854
    [Abstract] [Full Text] [Related]

  • 12. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium cross-links.
    Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):367-73. PubMed ID: 1991806
    [Abstract] [Full Text] [Related]

  • 13. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
    Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ.
    J Bone Miner Res; 1994 Oct; 9(10):1643-9. PubMed ID: 7817812
    [Abstract] [Full Text] [Related]

  • 14. Effect of pamidronate on excretion of pyridinium crosslinks of collagen after total hip arthroplasty.
    Wilkinson JM, Jackson B, Eastell R.
    Calcif Tissue Int; 2003 Oct; 73(4):326-31. PubMed ID: 12874697
    [Abstract] [Full Text] [Related]

  • 15. Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone.
    Alexandersen P, Peris P, Guañabens N, Byrjalsen I, Alvarez L, Solberg H, Cloos PA.
    J Bone Miner Res; 2005 Apr; 20(4):588-95. PubMed ID: 15765177
    [Abstract] [Full Text] [Related]

  • 16. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT, González-Casaus ML, Aguado P, Bernad M, Carrera F, Martínez ME.
    Osteoporos Int; 1999 Apr; 9(5):449-54. PubMed ID: 10550465
    [Abstract] [Full Text] [Related]

  • 17. The renal clearance of free and conjugated pyridinium cross-links of collagen.
    Colwell A, Eastell R.
    J Bone Miner Res; 1996 Dec; 11(12):1976-80. PubMed ID: 8970901
    [Abstract] [Full Text] [Related]

  • 18. Multiple molecular forms of pyridinolines cross-links excreted in human urine evaluated by chromatographic and immunoassay methods.
    Kamel S, Brazier M, Neri V, Picard C, Samson L, Desmet G, Sebert JL.
    J Bone Miner Res; 1995 Sep; 10(9):1385-92. PubMed ID: 7502711
    [Abstract] [Full Text] [Related]

  • 19. Urinary hydroxypyridinium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis.
    Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Lindsay R.
    J Bone Miner Res; 1993 Jul; 8(7):881-9. PubMed ID: 8352070
    [Abstract] [Full Text] [Related]

  • 20. Assessment of urinary pyridinoline excretion with a specific enzyme-linked immunosorbent assay in normal adults and in metabolic bone diseases.
    Arbault P, Grimaux M, Pradet V, Preaudat C, Seguin P, Delmas PD.
    Bone; 1995 Apr; 16(4):461-7. PubMed ID: 7605707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.